Literature DB >> 26666401

Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome.

Bart van den Munckhof1, Evelien E de Vries1, Kees P J Braun1, H Myrthe Boss1, Michèl A Willemsen2, Annet van Royen-Kerkhof3, Wilco de Jager3, Floor E Jansen1.   

Abstract

We aimed to study serum cytokine levels in 11 electrical status epilepticus in sleep (ESES) patients and 20 healthy control children. Patients showed significantly higher levels of interleukin (IL)-1α, IL-6, IL-10, chemokine (C-C motif) ligand (CCL)2 and chemokine (C-X-C motif) ligand (CXCL)8/IL-8 than controls, while macrophage migration inhibitory factor (MIF) and CCL3 were significantly lower. Follow-up analyses in five patients revealed a significant decrease of IL-6 levels after immunomodulating treatment. IL-6 changes were accompanied by clear improvement of electroencephalography (EEG) patterns and neuropsychological evaluation. We hypothesize that IL-6 correlates with disease activity and immunomodulating treatment efficacy. Wiley Periodicals, Inc.
© 2015 International League Against Epilepsy.

Entities:  

Keywords:  CSWS; Continuous spikes and waves during sleep; Cytokines; ESES; Electrical status epilepticus during sleep; Landau-Kleffner syndrome

Mesh:

Substances:

Year:  2015        PMID: 26666401     DOI: 10.1111/epi.13274

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

Review 1.  Neuroinflammatory mechanisms of post-traumatic epilepsy.

Authors:  Sanjib Mukherjee; Gabriel M Arisi; Kaley Mims; Gabriela Hollingsworth; Katherine O'Neil; Lee A Shapiro
Journal:  J Neuroinflammation       Date:  2020-06-17       Impact factor: 8.322

2.  CNKSR2 mutation causes the X-linked epilepsy-aphasia syndrome: A case report and review of literature.

Authors:  Ying Sun; Yi-Dan Liu; Zhi-Feng Xu; Qing-Xia Kong; Yan-Ling Wang
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

3.  Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*).

Authors:  Bart van den Munckhof; Alexis Arzimanoglou; Emilio Perucca; Heleen C van Teeseling; Frans S S Leijten; Kees P J Braun; Floor E Jansen
Journal:  Trials       Date:  2020-11-23       Impact factor: 2.279

4.  Pharmacological treatment for continuous spike-wave during slow wave sleep syndrome and Landau-Kleffner Syndrome.

Authors:  Luca Moresco; Matteo Bruschettini; Maria Grazia Calevo; Laura Siri
Journal:  Cochrane Database Syst Rev       Date:  2020-11-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.